|
|
Volumn 95, Issue 4, 2003, Pages
|
|
Re: A randomized, placebo-controlled trial of zoledronic acid in patients with hormone-refractory metastatic prostate carcinoma.
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANDROGEN;
ANTINEOPLASTIC AGENT;
BISPHOSPHONIC ACID DERIVATIVE;
IMIDAZOLE DERIVATIVE;
ZOLEDRONIC ACID;
BONE TUMOR;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
FRACTURE;
HUMAN;
MALE;
METABOLISM;
METASTASIS;
NOTE;
PAIN;
PATHOLOGY;
PROSTATE TUMOR;
QUALITY OF LIFE;
RANDOMIZED CONTROLLED TRIAL;
TREATMENT OUTCOME;
ANDROGENS;
ANTINEOPLASTIC AGENTS;
BONE NEOPLASMS;
DIPHOSPHONATES;
FRACTURES, BONE;
HUMANS;
IMIDAZOLES;
MALE;
PAIN;
PROSTATIC NEOPLASMS;
QUALITY OF LIFE;
RANDOMIZED CONTROLLED TRIALS;
TREATMENT OUTCOME;
|
|
EID: 0037453971
PISSN: 00278874
EISSN: None
Source Type: Journal
DOI: 10.1093/jnci/95.4.332-a Document Type: Note |
|
Times cited : (3)
|
|
References (0)
|
